SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K:重大事件
04/16 05:20
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 10-K:年度報表
03/30 01:23
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K:重大事件
03/29 21:37
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K:重大事件
03/09 05:31
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | S-8:員工福利計劃證券登記
02/24 11:18
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股變動聲明-高管 Bausch Christoph Lawrence
02/24 11:16
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股變動聲明-高管 Kropotova Alexandra
02/24 06:06
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股變動聲明-高管 Sullivan Eddie Joe
02/24 06:05
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股變動聲明-高管 King Michael
02/24 05:57
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股變動聲明-高管 Reich Samuel J
02/24 05:46
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-Commodore Capital LP(3.5%),Commodore Capital Master LP(3.5%)
02/15 07:07
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G:超過5%持股股東披露文件-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
02/14 20:06
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-Radcliffe Capital Management, L.P.(0.00%),RGC Management Company, LLC(0.00%)等
02/14 19:32
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K:重大事件
02/02 20:55
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K:重大事件
01/27 05:22
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 424B5:募資說明書
01/27 05:05
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K:重大事件
01/26 06:08
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K:重大事件
01/19 13:00
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K:重大事件
01/03 13:00
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | DEF 14A:股東委託書決議
2023/12/18 22:34
暫無數據
暫無數據